m6A-mediated upregulation of lncRNA-AC026356.1 promotes cancer stem cell maintenance in lung adenocarcinoma via activating Wnt signaling pathway
Aging · 15.05.2023 · 15 (9) · 3538-3548
DOI: 10.18632/aging.204689 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging, online erschienen am 03.05.2023. Verfasst von Zhen Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Affiliated Hospital of Hunan Academy of Traditional Chinese Medicine, Changsha 410006, P.R. China. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Lung Neoplasms, Adenocarcinoma. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
LncRNA plays a pivotal role in the stemness and drug resistance of lung cancer. Here, we found that lncRNA-AC026356.1 was upregulated in stem spheres and chemo-resistant lung cancer cells. Our fish assay also shows that AC026356.1 was predominantly located in the cytoplasm of lung cancer cells and does not have protein-coding potential. Silencing AC026356.1 significantly inhibited proliferation and migration but increased apoptosis in A549-cisplatin (DDP) cells. Additionally, IGF2BP2 and the lncRNA-AC026356.1 positively regulated the proliferation and stemness of stem-like lung cancer cells. Further mechanistic investigation revealed that METTL14/IGF2BP2-mediated m6A modification and stabilization of the AC026356.1 RNA. Functional analysis corroborated that AC026356.1 acted as a downstream target of METTL14/IGF2BP2 and AC026356.1 silencing could block the oncogenicity of lung cancer stem-like cells. AC026356.1 expression was correlated with immune cell infiltration and T cell exhaustion. Compared with paired adjacent normal tissues, lung cancer specimens exhibited consistently upregulated METTL14/IGF2BP2/AC026356.1. M6A-modified METTL14/IGF2BP2/AC026356.1 loop may serve as a potential therapeutic target and prognostic predictor for lung cancer therapy and diagnosis in the clinic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Affiliated Hospital of Hunan Academy of Traditional Chinese Medicine, Changsha 410006, P.R. China.
- School of Chinese Medicine, Hunan University of Chinese Medicine, Changsha 410208, P.R. China.
- Department of Medicine, UF Health Cancer Center, University of Florida, Gainesville, FL 32611, USA.
- Kunming College of Life Science, University of Chinese Academy of Sciences, Kunming, Yunnan, 650201, P.R. China.
- Department of Respiratory Medicine, Hospital of Traditional Chinese Medicine, Affiliated to Southwest Medical University, Luzhou 646000, P.R. China.
Zitieren
APA
Zhang, Z., Tan, X., Wu, R., Deng, T., Wang, H., Jiang, X., Zeng, P., & Tang, J. (2023). m6A-mediated upregulation of lncRNA-AC026356.1 promotes cancer stem cell maintenance in lung adenocarcinoma via activating Wnt signaling pathway. Aging, 15(9), 3538-3548. https://doi.org/10.18632/aging.204689
Vancouver
Zhang Z, Tan X, Wu R, Deng T, Wang H, Jiang X, et al. m6A-mediated upregulation of lncRNA-AC026356.1 promotes cancer stem cell maintenance in lung adenocarcinoma via activating Wnt signaling pathway. Aging. 2023;15(9):3538-3548. doi:10.18632/aging.204689
BibTeX
@article{Zhang2023,
author = {Zhang, Zhen and Tan, Xiaoning and Wu, Ruoxia and Deng, Tianhao and Wang, Huazhong and Jiang, Xiulin and Zeng, Puhua and Tang, Junqi},
title = {m6A-mediated upregulation of lncRNA-AC026356.1 promotes cancer stem cell maintenance in lung adenocarcinoma via activating Wnt signaling pathway},
journal = {Aging},
year = {2023},
volume = {15},
number = {9},
pages = {3538--3548},
doi = {10.18632/aging.204689}
}
EUVIMED